輸入代號或公司名稱後按 Enter
4108

懷特

-0.10 (-0.88%)最後更新 2026-09-15
台灣 · 上市 · 生技醫療業
11.30225成交張數本益比1.16股價淨值比0.00%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025135年增 -12.4%
毛利率202530.7%最新一期
營業利益率2025-129.7%最新一期
每股盈餘2025-0.29
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計50.1%55.2%48.8%33.4%50.4%53.6%57.9%58.4%58.3%69.3%
營業毛利(毛損)49.9%44.8%51.2%66.6%49.6%46.4%42.1%41.6%41.7%30.7%
營業毛利(毛損)淨額49.9%44.8%51.2%66.6%49.6%46.4%42.1%41.6%41.7%30.7%
推銷費用27.9%26.3%22.6%24.4%32.1%16.2%24.3%22.0%19.9%21.0%
管理費用332.3%157.8%86.5%85.3%67.2%37.2%45.3%37.6%42.4%45.7%
研究發展費用645.9%270.6%156.3%171.8%135.8%71.3%88.2%57.0%83.7%93.7%
預期信用減損損失(利益)0.1%-0.0%0.1%-0.1%-0.0%0.0%0.0%0.0%
營業費用合計1006.0%454.8%265.4%281.5%235.2%124.6%157.7%116.5%146.0%160.4%
營業利益(損失)-956.1%-497.0%-250.2%-247.0%-185.6%-78.2%-115.6%-74.9%-104.3%-129.7%
利息收入6.3%5.2%9.0%11.3%12.8%13.4%
其他收入100.8%45.4%56.8%32.1%32.5%15.5%21.0%18.1%21.1%33.9%
其他利益及損失淨額0.4%-0.1%-0.7%0.8%20.5%1.2%1.2%0.1%0.0%0.9%
財務成本淨額0.1%0.3%0.3%0.2%0.2%0.2%0.2%0.3%
營業外收入及支出合計101.2%45.3%55.9%32.5%59.0%21.7%31.0%29.3%33.6%47.9%
稅前淨利(淨損)-854.9%-451.7%-194.2%-214.4%-126.6%-56.5%-84.7%-45.6%-70.7%-81.8%
所得稅費用(利益)合計60.7%0.0%2.6%0.0%0.0%0.0%0.0%-0.0%
繼續營業單位本期淨利(淨損)-915.6%-451.7%-194.2%-214.4%-129.2%-56.5%-84.7%-45.6%-70.7%-81.8%
本期淨利(淨損)-915.6%-451.7%-194.2%-214.4%-129.2%-56.5%-84.7%-45.6%-70.7%-81.8%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-33.7%8.8%75.2%42.5%2.0%40.1%30.2%25.4%
不重分類至損益之項目:8.8%75.2%42.5%2.0%40.1%30.2%25.4%
其他綜合損益(淨額)2.8%9.5%-33.7%8.8%75.2%42.5%2.0%40.1%30.2%25.4%
本期綜合損益總額-912.8%-442.2%-228.0%-205.7%-54.0%-14.0%-82.6%-5.5%-40.5%-56.4%
母公司業主(淨利∕損)-777.4%-382.2%-169.8%-178.8%-96.1%-46.0%-58.6%-29.0%-47.9%-43.2%
非控制權益(淨利∕損)-138.2%-69.6%-24.5%-35.6%-33.1%-10.5%-26.1%-16.6%-22.8%-38.6%
母公司業主(綜合損益)-774.6%-372.7%-200.4%-166.0%-21.1%-5.6%-53.9%11.4%-19.8%-21.6%
非控制權益(綜合損益)-138.2%-69.6%-27.6%-39.6%-33.0%-8.5%-28.8%-16.9%-20.6%-34.8%
基本每股盈餘-4.8%-2.3%-1.0%-1.1%-0.6%-0.2%-0.3%-0.1%-0.2%-0.2%
其他收益及費損淨額-87.0%-36.0%-32.0%
確定福利計畫之再衡量數2.8%2.1%0.0%
備供出售金融資產未實現評價損益0.0%7.4%0.0%
繼續營業單位淨利(淨損)-0.0%-0.0%-0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。